Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: A systematic review of the experience in industrialized countries

@article{Giaquinto2011SummaryOE,
  title={Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: A systematic review of the experience in industrialized countries},
  author={C. Giaquinto and G{\'e}raldine Dominiak-Felden and P. van Damme and Tin Tin Htar Myint and Y. Maldonado and V. Spoulou and T. Mast and M. Staat},
  journal={Human Vaccines},
  year={2011},
  volume={7},
  pages={734 - 748}
}
  • C. Giaquinto, Géraldine Dominiak-Felden, +5 authors M. Staat
  • Published 2011
  • Medicine
  • Human Vaccines
  • The pentavalent rotavirus (RV) vaccine RotaTeq™ has been available in industrialized countries since 2006. Several studies have been conducted to evaluate the benefit of RV vaccination under routine conditions of use. A systematic review of all publicly available data from RotaTeq™ vaccine-effectiveness and vaccination-impact studies in the USA, Europe and Australia between 2006 and February 2010 was undertaken. Depending on the population studied, effectiveness of up to 100% (95% confidence… CONTINUE READING

    Topics from this paper.

    Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014.
    86
    Rotavirus vaccines: a story of success.
    32

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 83 REFERENCES
    RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe.
    73
    Rotavirus Vaccines in Belgium: Policy and Impact
    80
    Rotavirus Hospital Surveillance in the Era of Immunization
    3
    Cost-effectiveness and Potential Impact of Rotavirus Vaccination in the United States
    209